FDA publishes guidances on expanded access regulations

FDA issued two draft guidances composed of questions and answers on expanded access to investigational drugs or biologics and the circumstances in which companies can charge for an investigational drug. The guidances are part of the agency's implementation of 2009 final rules on expanded access. The first (see BioCentury, Aug. 9, 2009). ...